<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>333(7565)</volume><submitter>Ho KM</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To investigate the potential beneficial and adverse effects of frusemide to prevent or treat acute renal failure in adults.&lt;h4>Design&lt;/h4>Meta-analysis of randomised controlled trials.&lt;h4>Data sources&lt;/h4>Cochrane controlled trials register (2005 issue 4), Embase, and Medline (1966 to 1 February 2006), without language restrictions.&lt;h4>Review methods&lt;/h4>Two reviewers checked the quality of the studies and independently extracted data.&lt;h4>Results&lt;/h4>Nine randomised controlled trials totalling 849 patients with or at risk of acute renal failure were included. Outcome measures not significantly different after frusemide treatment were in-hospital mortality (relative risk 1.11, 95% confidence interval 0.92 to 1.33), risk for requiring renal replacement therapy or dialysis (</pubmed_abstract><journal>BMJ (Clinical research ed.)</journal><pagination>420</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC1553510</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Meta-analysis of frusemide to prevent or treat acute renal failure.</pubmed_title><pmcid>PMC1553510</pmcid><pubmed_authors>Ho KM</pubmed_authors><pubmed_authors>Sheridan DJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Meta-analysis of frusemide to prevent or treat acute renal failure.</name><description>&lt;h4>Objective&lt;/h4>To investigate the potential beneficial and adverse effects of frusemide to prevent or treat acute renal failure in adults.&lt;h4>Design&lt;/h4>Meta-analysis of randomised controlled trials.&lt;h4>Data sources&lt;/h4>Cochrane controlled trials register (2005 issue 4), Embase, and Medline (1966 to 1 February 2006), without language restrictions.&lt;h4>Review methods&lt;/h4>Two reviewers checked the quality of the studies and independently extracted data.&lt;h4>Results&lt;/h4>Nine randomised controlled trials totalling 849 patients with or at risk of acute renal failure were included. Outcome measures not significantly different after frusemide treatment were in-hospital mortality (relative risk 1.11, 95% confidence interval 0.92 to 1.33), risk for requiring renal replacement therapy or dialysis (</description><dates><release>2006-01-01T00:00:00Z</release><publication>2006 Aug</publication><modification>2025-04-19T13:09:24.457Z</modification><creation>2019-03-27T01:45:47Z</creation></dates><accession>S-EPMC1553510</accession><cross_references><pubmed>16861256</pubmed><doi>10.1136/bmj.38902.605347.7C</doi><doi>10.1136/bmj.38902.605347.7c</doi></cross_references></HashMap>